Class information for:
Level 1: DIRECT TO CONSUMER ADVERTISING//DTCA//DTC ADVERTISING

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
17606 527 37.2 41%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1294 8163 FOOD AND DRUG LAW JOURNAL//GENERIC SUBSTITUTION//DIRECT TO CONSUMER ADVERTISING

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DIRECT TO CONSUMER ADVERTISING Author keyword 50 59% 11% 56
2 DTCA Author keyword 15 82% 2% 9
3 DTC ADVERTISING Author keyword 4 67% 1% 4
4 DIRECT TO CONSUMER ADVERTISING DTCA Author keyword 4 75% 1% 3
5 DRUG ADVERTISING Author keyword 3 45% 1% 5
6 PATIENT REQUESTS Author keyword 3 50% 1% 4
7 PUBLIC POLICY REGULATION Author keyword 2 67% 0% 2
8 SUBJECT ADVOCACY PROGRAM Address 2 67% 0% 2
9 DIRECT TO CONSUMER Author keyword 2 14% 2% 12
10 MKT MED SERV Address 1 100% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 DIRECT TO CONSUMER ADVERTISING 50 59% 11% 56 Search DIRECT+TO+CONSUMER+ADVERTISING Search DIRECT+TO+CONSUMER+ADVERTISING
2 DTCA 15 82% 2% 9 Search DTCA Search DTCA
3 DTC ADVERTISING 4 67% 1% 4 Search DTC+ADVERTISING Search DTC+ADVERTISING
4 DIRECT TO CONSUMER ADVERTISING DTCA 4 75% 1% 3 Search DIRECT+TO+CONSUMER+ADVERTISING+DTCA Search DIRECT+TO+CONSUMER+ADVERTISING+DTCA
5 DRUG ADVERTISING 3 45% 1% 5 Search DRUG+ADVERTISING Search DRUG+ADVERTISING
6 PATIENT REQUESTS 3 50% 1% 4 Search PATIENT+REQUESTS Search PATIENT+REQUESTS
7 PUBLIC POLICY REGULATION 2 67% 0% 2 Search PUBLIC+POLICY+REGULATION Search PUBLIC+POLICY+REGULATION
8 DIRECT TO CONSUMER 2 14% 2% 12 Search DIRECT+TO+CONSUMER Search DIRECT+TO+CONSUMER
9 OVER THE COUNTER DRUG ADVERTISING 1 100% 0% 2 Search OVER+THE+COUNTER+DRUG+ADVERTISING Search OVER+THE+COUNTER+DRUG+ADVERTISING
10 PRESCRIPTION DRUG MARKETING 1 100% 0% 2 Search PRESCRIPTION+DRUG+MARKETING Search PRESCRIPTION+DRUG+MARKETING

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PRESCRIPTION DRUGS 23 22% 18% 95
2 NORMAL HUMAN EXPERIENCE 13 71% 2% 10
3 PRESCRIPTION DRUG ADVERTISEMENTS 12 75% 2% 9
4 PATIENTS REQUESTS 5 38% 2% 10
5 DTCA 4 75% 1% 3
6 FACTS BOX 4 75% 1% 3
7 PRESCRIPTION DRUG REQUESTS 3 100% 1% 3
8 DIRECT TO CONSUMER 3 60% 1% 3
9 LEARNED INTERMEDIARY DOCTRINE 2 67% 0% 2
10 PUBLIC POLICY IMPLICATIONS 2 67% 0% 2

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Advertising of Prescription-Only Medicines to the Public: Does Evidence of Benefit Counterbalance Harm? 2012 15 56 77%
Cancer-related direct-to-consumer advertising: a critical review 2011 16 34 44%
Direct-to-consumer advertising of pharmaceuticals 2007 33 13 85%
Benefits and harms of direct to consumer advertising: a systematic review 2005 65 10 80%
A history of drug advertising: The evolving roles of consumers and consumer protection 2006 17 35 46%
Does direct-to-consumer advertising affect patients' choice of pain medications? 2008 3 5 60%
Direct marketing of pharmaceuticals to consumers 2002 52 24 54%
The informative and persuasive components of pharmaceutical promotion An argument for why the two can coexist 2009 9 47 38%
A modest proposal to slow rising pharmaceutical prices: abolishing the tax exemption for broadcast, branded, direct-to-consumer advertising 2001 0 1 100%
Public policy issues in direct-to-consumer advertising of prescription drugs 2002 60 39 41%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 SUBJECT ADVOCACY PROGRAM 2 67% 0.4% 2
2 MKT MED SERV 1 100% 0.4% 2
3 RBB ARTHRIT 1 100% 0.4% 2
4 SOCIAL ADM SCI PHARM 1 50% 0.4% 2
5 DRUG MKT ADVERTISING COMMUN 1 33% 0.4% 2
6 BUSINESS ROUNDTABLE CORP ETH 1 50% 0.2% 1
7 FDA PRACTICE GRP 1 50% 0.2% 1
8 HLTH LAW POLICY GRP 1 50% 0.2% 1
9 IIS PUERTA DE HIERRO HOSP 1 50% 0.2% 1
10 LEON RECANATI BUSINESS 1 50% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000165157 CONFLICT OF INTEREST//CONFLICTS OF INTEREST//DRUG SAMPLES
2 0.0000141175 FOOD AND DRUG LAW JOURNAL//HUMANITARIAN DEVICE EXEMPTION//PREMARKET APPROVAL
3 0.0000118071 PHARMACEUTICALISATION//CRHAM//CORPORATE BIAS
4 0.0000109937 JOURNAL OF PUBLIC POLICY & MARKETING//ZWERLING FAMILY TERM CHAIR//DECEPTIVE ADVERTISING
5 0.0000103769 SUBSTANDARD DRUGS//ONLINE PHARMACIES//ONLINE PHARMACY
6 0.0000100079 MULTIPLE INDUSTRIES//RETURN ON INNOVATION//VALUE TRANSFERENCE
7 0.0000088175 THIRD PERSON EFFECT//HOSTILE MEDIA EFFECT//THIRD PERSON PERCEPTION
8 0.0000071843 GENERIC SUBSTITUTION//GENERIC DRUGS//REFERENCE PRICING
9 0.0000068626 WARNINGS//SIGNAL WORDS//SAFETY DATA SHEETS
10 0.0000061045 ACTIVATION SYNDROME//RISK EVALUATION AND MITIGATION STRATEGIES//REGULATORY ACTIONS